×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Videos
Maps
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
What Are The Drivers Of Biosynex SA's (EPA:ALBIO) Risks?
Yahoo Movies UK
If you're interested in Biosynex SA (EPA:ALBIO), then you might want to consider its beta (a measure of share price volatility) in order to understand how...
4 hours ago
Biosynex SA (EPA:ALBIO) Stock's 26% Dive Might Signal An Opportunity But It Requires Some Scrutiny
Simply Wall Street
Since its price has dipped substantially, Biosynex may be sending buy signals at present with its price-to-sales (or "P/S") ratio of 0.6x,...
2 months ago
ProciseDx Announces Acquisition by Biosynex S.A. to Transform Biologics Therapeutic Drug Monitoring in the US
PR Newswire
announces that it is being acquired by Biosynex S.A., a French diagnostics company that specializes in point of care testing. With the support...
11 months ago
ProciseDx Expands Intellectual Property Portfolio with Purchase of Two US Therapeutic Drug Monitoring Patents
BioSpace
SAN DIEGO, Oct. 18, 2023 /PRNewswire/ -- ProciseDx Inc. announces that it has purchased two US patents in therapeutic drug monitoring (TDM)...
7 months ago
White & Case Advises Biosynex on Merger Agreement With Chembio Diagnostics, Inc.
White & Case LLP
Global law firm White & Case LLP has advised Biosynex SA, a market-leading designer and distributor of rapid diagnostic tests, on its entry...
15 months ago
Chembio buys Qualigen's FastPack diagnostics business
Medical Device Network
Chembio Diagnostics has acquired the FastPack diagnostics business from Qualigen Therapeutics in an all-cash transaction.
10 months ago
Qualigen Therapeutics Divests FastPack® Diagnostics Business
GlobeNewswire
All cash deal with Chembio Diagnostics, a US Subsidiary of the French Diagnostics Company BIOSYNEX, SA, solidifies Qualigen's strategic...
10 months ago
French point-of-care testing firm Biosynex to acquire Chembio Diagnostics for $17.2M
LabPulse.com
“The acquisition of Chembio significantly advances our mission to develop, manufacture and market rapid diagnostics for screening, diagnosis and...
15 months ago
Chembio Diagnostics, Hauppauge maker of disease tests, to be bought by French firm for $17M
Newsday
A financially strapped Hauppauge-based manufacturer of diagnostic tests is being purchased by a French test maker for $17.2 million in cash,...
15 months ago
Pocket Laboratory Offers Fast and Reliable Diagnosis at Point of Care
HospiMedica International
A multi-technology, multi-parameters Point of Care (PoC) device combines two technologies in a single device for a unique evolutive panel of...
13 months ago